{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:39:56Z","timestamp":1792719596209,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.mayocp.2017.10.007","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T08:46:23Z","timestamp":1512549983000},"page":"40-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"title":["Rivaroxaban and Apixaban for Initial Treatment of Acute Venous Thromboembolism of Atypical Location"],"prefix":"10.1016","volume":"93","author":[{"given":"Dawid T.","family":"Janczak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata K.","family":"Mimier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"McBane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S.","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin S.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalene M.","family":"Bott-Kitslaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J.","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily R.","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David O.","family":"Hodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldemar E.","family":"Wysokinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.mayocp.2017.10.007_bib1","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1161\/CIR.0000000000000350","article-title":"Heart disease and stroke statistics\u20142016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.mayocp.2017.10.007_bib2","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/archinte.162.11.1245","article-title":"Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study","volume":"162","author":"Heit","year":"2002","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.mayocp.2017.10.007_bib3","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archinte.160.6.809","article-title":"Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study","volume":"160","author":"Heit","year":"2000","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.mayocp.2017.10.007_bib4","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1160\/TH16-07-0509","article-title":"Reasons for the persistent incidence of venous thromboembolism","volume":"117","author":"Heit","year":"2017","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.mayocp.2017.10.007_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4065\/mcp.2010.0339","article-title":"The association of active cancer with venous thromboembolism location: a population-based study","volume":"86","author":"Tafur","year":"2011","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.mayocp.2017.10.007_bib6","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cgh.2009.09.019","article-title":"Survival and recurrence in patients with splanchnic vein thromboses","volume":"8","author":"Thatipelli","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.mayocp.2017.10.007_bib7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1053\/j.ajkd.2007.10.030","article-title":"Clinical characteristics and long-term follow-up of patients with renal vein thrombosis","volume":"51","author":"Wysokinski","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.mayocp.2017.10.007_bib8","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/AOG.0000000000002319","article-title":"Ovarian vein thrombosis: incidence of recurrent venous thromboembolism and survival","volume":"130","author":"Lenz","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.mayocp.2017.10.007_bib9","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1212\/01.wnl.0000233887.17638.d0","article-title":"Cerebral venous sinus thrombosis: incidence of venous thrombosis recurrence and survival","volume":"67","author":"Gosk-Bierska","year":"2006","journal-title":"Neurology"},{"issue":"26","key":"10.1016\/j.mayocp.2017.10.007_bib10","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Bauersachs","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.mayocp.2017.10.007_bib11","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","article-title":"Oral rivaroxaban for the treatment of symptomatic pulmonary embolism","volume":"366","author":"B\u00fcller","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.mayocp.2017.10.007_bib12","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1302507","article-title":"Oral apixaban for the treatment of acute venous thromboembolism","volume":"369","author":"Agnelli","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.mayocp.2017.10.007_bib13","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s10620-015-4012-2","article-title":"Direct oral anticoagulants in cirrhosis patients pose similar risks of bleeding when compared to traditional anticoagulation","volume":"61","author":"Intagliata","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.mayocp.2017.10.007_bib14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/ejh.12844","article-title":"The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis","volume":"98","author":"Hum","year":"2017","journal-title":"Eur J Haematol"},{"issue":"5","key":"10.1016\/j.mayocp.2017.10.007_bib15","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/liv.13285","article-title":"Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis","volume":"37","author":"De Gottardi","year":"2017","journal-title":"Liver Int"},{"issue":"10","key":"10.1016\/j.mayocp.2017.10.007_bib16","first-page":"1175","article-title":"Successful treatment of partial portal vein thrombosis (PVT) with low dose rivaroxaban","volume":"52","author":"Lenz","year":"2014","journal-title":"Z\u00a0Gastroenterol"},{"issue":"4","key":"10.1016\/j.mayocp.2017.10.007_bib17","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1160\/TH13-05-0407","article-title":"Successful treatment of acute portal vein thrombosis with rivaroxaban","volume":"110","author":"Pannach","year":"2013","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.mayocp.2017.10.007_bib18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3350\/cmh.2016.0016","article-title":"Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban","volume":"22","author":"Yang","year":"2016","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"10.1016\/j.mayocp.2017.10.007_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.14740\/gr806w","article-title":"Efficacy and safety of direct-acting oral anticoagulants use in acute portal vein thrombosis unrelated to cirrhosis","volume":"10","author":"Nery","year":"2017","journal-title":"Gastroenterology Res"},{"issue":"1","key":"10.1016\/j.mayocp.2017.10.007_bib20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.5217\/ir.2016.14.1.96","article-title":"Cerebral venous thrombosis in a patient with Crohn's disease","volume":"14","author":"Cho","year":"2016","journal-title":"Intest Res"},{"key":"10.1016\/j.mayocp.2017.10.007_bib21","doi-asserted-by":"crossref","first-page":"e629","DOI":"10.1097\/MJT.0000000000000512","article-title":"Use of rivaroxaban for mesenteric vein thrombosis secondary to diverticulitis: a case report","volume":"24","author":"Parthvi","year":"2017","journal-title":"Am J Ther"},{"issue":"6","key":"10.1016\/j.mayocp.2017.10.007_bib22","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.amjmed.2015.12.025","article-title":"Efficacy and safety of rivaroxaban in patients with venous thromboembolism and active malignancy: a single-center registry","volume":"129","author":"Bott-Kitslaar","year":"2016","journal-title":"Am J Med"},{"issue":"15","key":"10.1016\/j.mayocp.2017.10.007_bib23","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/archinternmed.2010.199","article-title":"Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism","volume":"170","author":"Jim\u00e9nez","year":"2010","journal-title":"Arch Intern Med"},{"issue":"2, Supplement","key":"10.1016\/j.mayocp.2017.10.007_bib24","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.mayocp.2017.10.007_bib25","series-title":"NCCN clinical practice guidelines: venous thromboembolism disease, Version 2","year":"2014"},{"issue":"2","key":"10.1016\/j.mayocp.2017.10.007_bib26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and Expert Panel Report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.mayocp.2017.10.007_bib27","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1378\/chest.14-0402","article-title":"Direct oral anticoagulants in patients with VTE and cancer: a systematic review and meta-analysis","volume":"147","author":"Vedovati","year":"2015","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.mayocp.2017.10.007_bib28","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0002-8703(84)90558-1","article-title":"International diagnostic criteria for acute myocardial infarction and acute stroke","volume":"108","author":"Gillum","year":"1984","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.mayocp.2017.10.007_bib29","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"10.1016\/j.mayocp.2017.10.007_bib30","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1053\/gast.2001.21209","article-title":"Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy","volume":"120","author":"Condat","year":"2001","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.mayocp.2017.10.007_bib31","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/jth.12121","article-title":"Anticoagulant therapy in patients with non-cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding","volume":"11","author":"Spaander","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"issue":"9","key":"10.1016\/j.mayocp.2017.10.007_bib32","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1001\/jamainternmed.2015.3184","article-title":"Long-term clinical outcomes of splanchnic vein thrombosis: results of an international registry","volume":"175","author":"Ageno","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.mayocp.2017.10.007_bib33","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1160\/TH16-07-0494","article-title":"Real-life treatment of venous thromboembolism with direct oral anticoagulants: the influence of recommended dosing and regimens","volume":"117","author":"Trujillo-Santos","year":"2017","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.mayocp.2017.10.007_bib34","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/hep.27541","article-title":"Use of nontraditional anticoagulants in portal vein thrombosis: a note of caution","volume":"61","author":"Simonetto","year":"2015","journal-title":"Hepatology"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619617307401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619617307401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T18:04:53Z","timestamp":1530641093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619617307401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0025619617307401"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2017.10.007","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rivaroxaban and Apixaban for Initial Treatment of Acute Venous Thromboembolism of Atypical Location","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2017.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}